
Anti-Inflammatory Agents, Common Cold, Ascorbic Acid, General & Internal, Echinacea, 730110 Respiratory system and diseases (incl. asthma), C1, Anti-Infective Agents, Humans, Respiratory Tract Infections, Randomized Controlled Trials as Topic, Analgesics, 321208 Primary Health Care, Evidence-Based Medicine, 321027 Respiratory Diseases, Anti-Inflammatory Agents, Non-Steroidal, Bacterial Infections, Adrenergic beta-Agonists, Anti-Bacterial Agents, Nasal Decongestants, Zinc, Treatment Outcome, 2700 Medicine, Histamine H1 Antagonists, Medicine, Plant Preparations, 730101 Infectious diseases, Family Practice, Phytotherapy
Anti-Inflammatory Agents, Common Cold, Ascorbic Acid, General & Internal, Echinacea, 730110 Respiratory system and diseases (incl. asthma), C1, Anti-Infective Agents, Humans, Respiratory Tract Infections, Randomized Controlled Trials as Topic, Analgesics, 321208 Primary Health Care, Evidence-Based Medicine, 321027 Respiratory Diseases, Anti-Inflammatory Agents, Non-Steroidal, Bacterial Infections, Adrenergic beta-Agonists, Anti-Bacterial Agents, Nasal Decongestants, Zinc, Treatment Outcome, 2700 Medicine, Histamine H1 Antagonists, Medicine, Plant Preparations, 730101 Infectious diseases, Family Practice, Phytotherapy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
